Cargando…

Rheumatoid Arthritis: Refractory to Infliximab, a Tumor Necrosis Factor Inhibitor

Rheumatoid arthritis is one of the commonest autoimmune diseases. It is a chronic, progressive, systemic inflammatory disorder affecting the synovial joints and typically producing symmetrical arthritis. If left untreated, it leads to joint destruction and thus deformity and disability. In the recen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solehan, Hana Maizuliana bt, Said, Mohd Shahrir Mohamed, Shaharir, Sazliyana, Rajalingham, Sakthiswary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2011
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279492/ https://www.ncbi.nlm.nih.gov/pubmed/22383918 http://dx.doi.org/10.4021/jocmr630w

Ejemplares similares

Frequency and Clinical Significance of Elevated IgG4 in Rheumatoid Arthritis: A Systematic Review
por: Sakthiswary, Rajalingham, et al.
Publicado: (2022)

Etanercept in the treatment of recalcitrant enteropathic arthritis: a case report
por: Mohamed Said, Mohd Shahrir, et al.
Publicado: (2012)

Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort
por: Shaharir, Syahrul Sazliyana, et al.
Publicado: (2021)

The Clinical Significance of Interleukin–1 Receptor Antagonist +2018 Polymorphism in Rheumatoid Arthritis
por: Ismail, Endom, et al.
Publicado: (2016)

Damage in the Multiethnic Malaysian Systemic Lupus Erythematosus (SLE) Cohort: Comparison with Other Cohorts Worldwide
por: Shaharir, Syahrul Sazliyana, et al.
Publicado: (2016)

Decoding the Clinical Significance of Immunoglobulin G4 in Rheumatoid Arthritis
por: Tan, Li Fen, et al.
Publicado: (2023)

Beyond the joints in rheumatoid arthritis: Effects of adalimumab on hematologic and lipid indices
por: Sakthiswary, R., et al.
Publicado: (2012)

Predictors of diastolic dysfunction in rheumatoid arthritis
por: Sakthiswary, Rajalingham, et al.
Publicado: (2015)

Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Burska, Agata N., et al.
Publicado: (2015)

Predictors of SLE relapse in pregnancy and post-partum among multi-ethnic patients in Malaysia
por: Shaharir, Syahrul Sazliyana, et al.
Publicado: (2019)

Predictors of frequent oral analgesic use in rheumatoid arthritis
por: Gupta, Esha das, et al.
Publicado: (2014)

Pathomechanisms of bone loss in rheumatoid arthritis
por: Sakthiswary, Rajalingham, et al.
Publicado: (2022)

Understanding COVID-19 vaccine hesitancy in Malaysia: Public perception, knowledge, and acceptance
por: Mohamed, Nurul Azmawati, et al.
Publicado: (2023)

Knowledge, acceptance and perception on COVID-19 vaccine among Malaysians: A web-based survey
por: Mohamed, Nurul Azmawati, et al.
Publicado: (2021)

Assessment of acceptability of the COVID-19 vaccine based on the health belief model among Malaysians-A qualitative approach
por: Rani, Mohd Dzulkhairi Mohd, et al.
Publicado: (2022)

Effects of Methotrexate Therapy on the Levels of Gonadotropic Hormones in Rheumatoid Arthritis Patients of Reproductive Age
por: Kyaw, Min Tun, et al.
Publicado: (2020)

Methotrexate-Associated Nonalcoholic Fatty Liver Disease with Transaminitis in Rheumatoid Arthritis
por: Sakthiswary, Rajalingham, et al.
Publicado: (2014)

Recurrent and refractory corneal perforation secondary to rheumatoid arthritis treated with infliximab
por: Al Saleh, Ahmed, et al.
Publicado: (2021)

Infliximab in the treatment of rheumatoid arthritis
por: Perdriger, A
Publicado: (2009)

74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis
por: Delabaye, Isabelle, et al.
Publicado: (2010)

Anti-cyclic citrullinated peptide antibody is a good indicator for the diagnosis of rheumatoid arthritis
por: Abdul Wahab, Asrul, et al.
Publicado: (2013)

Personal Protective Equipment (PPE) and Its Use in COVID-19: Important Facts
por: Das, Srijit, et al.
Publicado: (2020)

Septic Arthritis in Rheumatology: Review of Five Cases
por: Muhayidina, Azura Dina, et al.
Publicado: (2009)

Involvement of Gut Microbiota in SLE and Lupus Nephritis
por: Mohd, Rozita, et al.
Publicado: (2023)

How does infliximab work in rheumatoid arthritis?
por: Maini, Ravinder N, et al.
Publicado: (2002)

Rheumatoid arthritis serotype and synthetic disease-modifying anti-rheumatic drugs in patients with periodontitis: A case-control study
por: Nik-Azis, Nik-Madihah, et al.
Publicado: (2021)

Chronic necrotizing pulmonary aspergillosis presenting as bilateral pleural effusion: a case report
por: Rajalingham, Sakthiswary, et al.
Publicado: (2012)

The Clinical Significance of Vitamin D in Systemic Lupus Erythematosus: A Systematic Review
por: Sakthiswary, Rajalingham, et al.
Publicado: (2013)

Stem cell therapy in neurodegenerative diseases: From principles to practice
por: Sakthiswary, Rajalingham, et al.
Publicado: (2012)

Intravenous Immunoglobulin in the Therapeutic Armamentarium of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
por: Sakthiswary, Rajalingham, et al.
Publicado: (2014)

Antinuclear antibodies in primary osteoarthritis of the knee: a case-control study
por: Sakthiswary, Rajalingham, et al.
Publicado: (2012)

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor α expression in the synovium
por: Wijbrandts, C A, et al.
Publicado: (2008)

Circulating tumour necrosis factor-α bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response
por: Marotte, Hubert, et al.
Publicado: (2005)

Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
por: Neovius, M, et al.
Publicado: (2015)

Infliximab improves vascular stiffness in patients with rheumatoid arthritis
por: Wong, M, et al.
Publicado: (2008)

Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis
por: Takeuchi, Tsutomu, et al.
Publicado: (2011)

Response to Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis for Function and Pain is Affected by Rheumatoid Factor
por: Aberumand, Babak, et al.
Publicado: (2014)

Antibodies against cyclic citrullinated peptide don’t decrease after 6 months of infliximab treatment in refractory rheumatoid arthritis
por: Kolarz, Bogdan, et al.
Publicado: (2010)

A systematic review of infliximab in the treatment of early rheumatoid arthritis
por: Du Pan, Sophie Martin, et al.
Publicado: (2007)

The effects of infliximab therapy on the serum proteome of rheumatoid arthritis patients
por: Dwivedi, Ravi C, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_strat52gfmii1pp4jkdc9i5vjg